SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-000795
Filing Date
2020-02-11
Accepted
2020-02-11 07:57:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT a2240685z424b5.htm 424B5 482493
2 G906052.JPG g906052.jpg GRAPHIC 12943
3 G125124.JPG g125124.jpg GRAPHIC 14901
  Complete submission text file 0001047469-20-000795.txt   522653
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-236162 | Film No.: 20593987
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-236162-01 | Film No.: 20593988
SIC: 2834 Pharmaceutical Preparations